Company intelligence / Profile preview

Paramita Therapeutics, Inc.

San Diego, California, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

Paramita Therapeutics, Inc. is an early-stage biotechnology company developing targeted immunotherapies for cancer and novel dual-function therapeutics/vaccines for infectious diseases such as COVID‑19. The company leverages proprietary water-soluble multivalent conjugation technologies to create innovative therapies. It has received a competitive Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation to support its R&D efforts on a dual-function COVID‑19 product. As of now, the company remains preclinical with no reported clinical trial results or commercialized products.[1][2][3][4]

Therapeutic areas: OncologyInfectious Diseases
Modalities: Immunotherapies (targeted)Water-soluble multivalent conjugation platforms[1][3][4]Dual-function therapeutic/vaccine products[2][5]
Industry: Biotech

Drug pipeline

1 asset

TheraVax

Pre-clinical

Indications: COVID-19

Beyond the preview

Go deeper on Paramita Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paramita Therapeutics, Inc..

Explore the full profile